Relationship Between Aspirin Use and Cancer
Aspirin is one of the drugs that are used frequently in the world and that you have heard of. This drug, which is a pain reliever, is also used as an antipyretic and blood thinner. Apart from this, it is also given in inflammatory diseases such as rheumatoid arthritis.
This drug, which should be used carefully, prevents blood clotting as a result of using minimal doses, and thus the recurrence of heart attack or stroke can be prevented.
Aspirin contains an active ingredient called acetylsalicylic acid. This anti-inflammatory drug must be taken under the control of a physician.
Relationship Between Aspirin and Cancer
Many studies have been conducted on the relationship between aspirin and cancer and this relationship is still being investigated.
In a study conducted by Cardiff University, one of the pioneers of scientific studies in England, it was suggested that the use of aspirin in cancer patients may reveal important results in the treatment. Peter Elwood, who is at the beginning of the research, made the following comment on this subject.
According to the professor, patients with cancer reported 20 percent greater survival on treatment than patients who did not use aspirin. It has been claimed that taking low doses of aspirin over five years may reduce the incidence of uterine cancer, colon cancer, sarcoma and lymphoma. But recommendations on this are not clear.
In another study, it was concluded that aspirin taken regularly reduces the formation of cancer in the gastrointestinal area, including liver and pancreatic cancers. According to the results published in the Annals of Oncology, aspirin has a positive effect. Long-term use has been shown to further minimize the risk of colorectal cancer.
At this point, cancers that may arise in the digestive system as a result of regular use of aspirin have emerged as 22-38 percent less risky than individuals who do not use aspirin. Apart from this, it is thought that it has no effect on head and neck cancer, but current studies are continuing. Studies on aspirin, which can be used as a strategic move in cancer prevention, are still ongoing, but there is no clarity on the final results.
